Quality Of Life – A Rarely Acknowledged Key Category Within The Amnog Process in Germany von Eheberg, D, Shlaen, R, Batscheider, A, Gohlke, A

Volltext

Epidemiology and Unmet Medical Need in Diabetes Mellitus Type 2 in Germany –Results of a Literature Search von Greiner, R.A, Paulus, G, Driedger, J, Schröder, C, Timtschenko, V, Batscheider, A, Eheberg, D, Vosgerau, S

Volltext

Burden of Actinic Keratosis in Germany-Results of a Literature Research von Pfiffner, C, Macheleidt, O, Batscheider, A, Ehlken, B, Greiner, R.A, Schroeder, C, Hutt, H.J

Volltext

PHP199 The Impact of the German Pharmaceutical Market Reorganisation Act (AMNOG) on the German Reference Price Market – Trends Two Years After the Introduction of the AMNOG von Eheberg, D, Batscheider, A, Lebioda, A, Plantör, S, Fricke, F.U

Volltext

Methodological Challenges in Comparing Topical Therapies in Dermatology in the Absence of Head to Head Studies von Greiner, R.A, Batscheider, A, Eheberg, D, Gohlke, A, Pfiffner, C, Ehlken, B, Macheleidt, O, Hutt, H.J

Volltext

Health-Related Quality of Life (Hrqol) In Splenectomized Immune Thrombocytopenia (Itp) Patients – A Targeted Literature Review von Lebioda, A, Batscheider, A

Volltext

PSY98 - Health-Related Quality of Life (Hrqol) In Splenectomized Immune Thrombocytopenia (Itp) Patients – A Targeted Literature Review von Lebioda, A, Batscheider, A

Volltext

EPH109 Predictors of Individual General Life Satisfaction in the German General Social Survey (ALLBUS) Cohorts from 2010 to 2021 von Pfaff, H.U., Meier, C., Rauch, M., Falk, L., Akkuliyeva, A., Batscheider, A., Mattern, F.

Volltext

PT25 Comparison of Approval Dates of New Substances Between the United States of America (Food and Drug Administration, FDA) and Europe (European Medicines Agency, EMA) von Batscheider, A., Weiß, K., Schnauffer, D., Al-Khalaf, A., Greiner, R.A., Shlaen, E.

Volltext

HTA85 Possible Impact of Orphan Threshold Reduction to 20 Million Euro in the Framework of Early Benefit Assessment and Reimbursement Price in Germany von Batscheider, A, Shlaen, E, Rich, A, Meier, C, Weiß, K, Kovacevic, S, Greiner, RA

Volltext

POSC253 Analysis of Result of Early Benefit Assessment and Reimbursement Price After Free-Pricing Period in Germany von Batscheider, A, Shlaen, E, Rich, A, Strimitzer, K, Greiner, RA

Volltext

POSA190 Socio-Economic Influences on County-Level Differences in COVID-19 Incidence During the Second Wave in Germany von Gossmann, JA, Meier, C, Greiner, RA, Otto, J, Shlaen, E, Batscheider, A

Volltext

PSS53 - ORIGINATOR AND GENERIC MARKET ACCESS PROTECTION STRATEGIES IN GERMANY USING DERMATOLOGY AS AN EXAMPLE von Greiner, R., Batscheider, A., Stratil, A., Antoni, B., Bonduelle, D.

Volltext

PIN78 County-level differences in COVID-19 cases and fatalities in Germany von Batscheider, A., Gossmann, J.A., Greiner, R.A., Shlaen, E., Antoni, B., Böckmann, D., Mittal, R., Böhm, D.

Volltext

Implications of the German HTA-Process on Market-Uptake of Oral Treatments for Type-2-Diabetes (T2DM) Since 2007 von Greiner, R, Fischer, T, Antoni, B, Batscheider, A

Volltext

PDB69 - Implications of the German HTA-Process on Market-Uptake of Oral Treatments for Type-2-Diabetes (T2DM) Since 2007 von Greiner, R, Fischer, T, Antoni, B, Batscheider, A

Volltext

PIN129 ANALYSIS OF THE RELATIONSHIP BETWEEN HEALTH TECHNOLOGY ASSESSMENT (HTA) EVALUATION AND REIMBURSED PRICE OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) COMBINATION DRUGS IN EU-3 (FRAN... von Roxlau, T., Batscheider, A., Bonduelle, D., Greiner, R.A., Lukas, M., Antoni, B., Schwarzhans, J.P.

Volltext

PMU105 ACCEPTANCE OF EVIDENCE TRANSFER FROM ADULTS TO CHILDREN IN THE CONTEXT OF BENEFIT ASSESSMENT IN GERMANY, FRANCE, AND UK von Weihing, J., Roxlau, T., Bocuk, D., Batscheider, A., Greiner, R.A., Eheberg, D., Bonduelle, D.

Volltext

PHP237 - OVERVIEW OF GERMAN AMNOG DOSSIERS WITH PRICE ANALYSIS BEFORE AND AFTER EARLY BENEFIT ASSESSMENT von Bonduelle, D., Batscheider, A., Tremmel, M., Antoni, B., Bocuk, D., Roxlau, T., Mihaylova, E.

Volltext

From Centralized Marketing Authorization to National Reimbursement – A Challenging Journey for New Medical Products with Placebo Controlled Trials von Eheberg, D, Paulus, G, Dannemann, S, Batscheider, A

Volltext